- Health A to Z
- Healthy Living
News: May 28, 2012
Hepatitis C Causing Liver Damage in Greater Numbers: Study
TUESDAY, May 22 (HealthDay News) -- Hundreds of thousands of Americans infected with chronic hepatitis C virus could develop potentially life-threatening liver complications over the next few years, according to a new study. Researchers evaluated ...
Test Baby Boomers for Hepatitis C, Says CDC
FRIDAY, May 18 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention wants all Americans born between 1945 and 1965 -- the baby boom generation -- tested for hepatitis C. Most cases of the potentially deadly disease occur in this...
Stem Cells May Further Hepatitis C Research
TUESDAY, Jan. 31 (HealthDay News) -- Using stem cells to create liver-like cells for laboratory research may advance efforts to find out why people respond differently to hepatitis C infection, scientists say. It's not clear why some people are re...
Statins May Stave Off Liver Cancer in People With Hepatitis B
THURSDAY, Jan. 26 (HealthDay News) -- Popular cholesterol-lowering statins may also lower risk for liver cancer among people with hepatitis B, a new study shows. Hepatitis B, an inflammation of the liver due to the hepatitis B virus, is one of the...
Hepatitis B Vaccine Recommended for Adults With Diabetes
THURSDAY, Dec. 22 (HealthDay News) -- Hepatitis B vaccination is recommended for all unvaccinated adults with type 1 and type 2 diabetes aged 19 to 59, say new guidelines from the U.S. Advisory Committee on Immunization Practices (ACIP). The vacci...
Change in Hepatitis Screening May Save Lives, Money
FRIDAY, Nov. 4 (HealthDay News) -- Primary care-based screening for hepatitis C in people born between 1945 and 1965 is cost-effective and lifesaving, a new study says. This type of screening could identify more than 800,000 undiagnosed cases of h...
Hepatitis May Lurk at Barbershops, Nail Salons
TUESDAY, Nov. 1 (HealthDay News) -- Customers in nail salons and barbershops may be at risk for hepatitis infection if the tools used are improperly cleaned, a new U.S. study suggests. While regulations for disinfecting instruments such as nail fi...
Hepatitis Rates Soar Among IV Drug Users, Study Finds
WEDNESDAY, July 27 (HealthDay News) -- About 10 million injection drug users worldwide have hepatitis C, and 1.3 million have hepatitis B, a new study reports. Hepatitis can lead to cirrhosis, liver failure and liver cancer.
New Drug Effectively Treats Hepatitis C
WEDNESDAY, June 22 (HealthDay News) -- The recently approved drug Incivek, combined with two standard drugs, is highly effective at treating hepatitis C, a notoriously difficult-to-manage liver disease, two new studies show. The drug works not onl...
FDA Approves Another New Drug to Fight Hepatitis C
MONDAY, May 23 (HealthDay News) -- The U.S. Food and Drug Administration on Monday approved Incivek (telaprevir), one of a new class of drugs, to fight chronic hepatitis C infection. The approval comes after the agency gave a thumbs-up on May 13 t...
Incivek Approved for Hepatitis C
MONDAY, May 23 (HealthDay News) -- Incivek (telaprevir) has been approved by the U.S. Food and Drug Administration for adults with chronic hepatitis C infection who either haven't received standard interferon therapy or haven't responded to it. Th...
Victrelis Approved for Chronic Hepatitis C
MONDAY, May 16 (HealthDay News) -- Victrelis (boceprevir) has been approved by the U.S. Food and Drug Administration to treat chronic hepatitis C, in tandem with the two additional drugs, pegylated interferon alfa and ribavirin. Victrelis was eval...
FDA Approves New Drug to Fight Hepatitis C
FRIDAY, May 13 (HealthDay News) -- The U.S. Food and Drug Administration late Friday gave approval to Victrelis (boceprevir), one of a new class of drugs aimed at fighting chronic hepatitis C infection. According to The New York Times, the new dru...
New Hepatitis C Drug Close to Gaining FDA Approval
THURSDAY, April 28 (HealthDay News) -- Boceprevir, a new medication from Merck & Co. that changes the way hepatitis C is treated, won unanimous support Wednesday from a panel of experts convened by the U.S. Food and Drug Administration. The drug i...
Novel Hepatitis C Drug Holds Promise: FDA
WEDNESDAY, April 27 (HealthDay News) -- An experimental new drug that may treat hepatitis C more effectively than earlier medications will be reviewed Thursday by a panel of experts for the U.S. Food and Drug Administration. Telaprevir, made by Ve...
Infectious Disease Experts Call for More Focus on Hepatitis C
TUESDAY, Feb. 1 (HealthDay News) -- Among injection drug users, new cases of HIV infection have declined dramatically in the past two decades, but the number of new infections from the hepatitis C virus have dropped only a small amount, a new stud...
Better Hepatitis C Surveillance Helps Public, CDC Finds
FRIDAY, Nov. 5 (HealthDay News) -- Enhanced surveillance of acute hepatitis C infections in the United States offers more timely and complete case reporting that provides greater benefits to public health, a new study concludes. Each year in the U...
Race Affects Hepatitis C Recurrence After Liver Transplant
SATURDAY, Oct. 30 (HealthDay News) -- Hepatitis C patients who receive a liver from a white donor have significantly more aggressive recurrent hepatitis than those who receive a liver from a black donor, researchers have found. This is especially ...
Race Affects Hepatitis C Recurrence After Liver Transplant: Study
SATURDAY, Oct. 30 (HealthDay News) -- Hepatitis C patients who receive a liver from a white donor have significantly more aggressive recurrent hepatitis than those who receive a liver from a black donor, researchers have found. This is especially ...
Hepatitis E Vaccine Appears Safe, Effective
MONDAY, Aug. 23 (HealthDay News) -- A new vaccine designed to protect individuals from becoming infected with the hepatitis E virus appears to be virtually foolproof, ongoing Chinese research indicates. After analyzing results from the third phase...
Adding Third Drug May Improve Hepatitis C Treatment
MONDAY, Aug. 9 (HealthDay News) -- The current two-drug standard treatment for the potentially lethal hepatitis C could be rendered nearly twice as effective if doctors added in a third antiviral medication called boceprevir, new research suggests...
Success of Hepatitis C Drugs May Depend on Gene Variant
SATURDAY, June 12 (HealthDay News) -- A genetic variant associated with poor response to treatment for hepatitis C infection has been identified by scientists. The researchers analyzed the DNA of 1,362 hepatitis C patients and pinpointed the varia...
Many Kids With Hepatitis C Are Missed
SUNDAY, May 2 (HealthDay News) -- Many children with hepatitis C go undiagnosed and untreated, which can lead to severe liver damage later in life, a new study warns. Researchers from the University of Miami Miller School of Medicine noted that na...
In Early Test, New Hepatitis C Drug Shows Promise
WEDNESDAY, April 21 (HealthDay News) -- Researchers are reporting that a drug is showing promise in early testing as a possible new treatment for hepatitis C, a stubborn and potentially deadly liver ailment. It's too early to tell if the drug actu...
Hepatitis C Tied to Higher Kidney Cancer Risk
FRIDAY, April 9 (HealthDay News) -- People infected with the hepatitis C virus are at much higher risk of developing kidney cancer, new research suggests. A study of more than 67,000 patients enrolled in the Henry Ford Health System from 1997-2008...
Hundreds of Donor Kidneys Tossed Away Each Year
THURSDAY, April 1 (HealthDay News) -- Every year, hundreds of kidneys are thrown out because they may be infected with hepatitis C, but they could help many hepatitis C-infected patients waiting for a transplant, Johns Hopkins researchers report. ...
Indian Spice May Thwart Liver Damage
THURSDAY, March 25 (HealthDay News) -- Curcumin -- a component of the Indian spice turmeric -- may delay the inflammation-related liver damage that leads to cirrhosis, according to a new study in the journal Gut. Another study in the same issue of...
Vaccination, Prevention Is Beating Back Hepatitis
WEDNESDAY, March 10 (HealthDay News) -- Decades of vaccination and prevention efforts may have the hepatitis viruses on the run, according to a new report from the U.S. Centers for Disease Control and Prevention. The CDC researchers tracked indivi...
1 in 5 At-Risk U.S. Babies Doesn't Get Hepatitis B Vaccine
MONDAY, March 8 (HealthDay News) -- About one in five babies born to mothers with hepatitis B aren't getting treatments that have been shown to prevent the infection in newborns, a new study finds. Given within 24 hours of birth, the hepatitis B v...
New Treatment Eyed for Hepatitis C
WEDNESDAY, Jan. 20 (HealthDay News) -- A new class of compounds is able to inhibit replication of the hepatitis C virus (HCV) in laboratory tests, say U.S. scientists. If they prove effective in humans, these compounds may offer an important new t...
Key to Hepatitis C May Be Two Cellular Proteins
FRIDAY, Jan. 8 (HealthDay News) -- Researchers have identified two cellular proteins that play an important role in hepatitis C infection, and they say the finding may point to new and less toxic treatments for the disease, which can lead to cirrh...
Herb May Counter Liver Damage From Chemo
MONDAY, Dec. 14 (HealthDay News) -- A medicinal herb, milk thistle, appears to reduce liver damage resulting from chemotherapy, a new study finds. Chemo drugs often cause liver inflammation, making it necessary to lower the dose or suspend treatme...
New Hepatitis C Treatment Shows Promise
THURSDAY, Dec. 3 (HealthDay News) -- A new drug to treat hepatitis C has shown promise in a primate study. The drug, called SPC3649, uses a new strategy to prevent the hepatitis C virus from replicating. Unlike other antivirals that target the vir...
Coffee May Slow Liver Disease
FRIDAY, Oct. 23 (HealthDay News) -- Coffee slows the progression of advanced liver disease in people with chronic hepatitis C, new research finds. The study included 766 patients infected with hepatitis C virus (HCV) who were asked to report their...
Truckers Trailed By Risky Behaviors: Study
FRIDAY, Oct. 9 (HealthDay News) -- Prevention programs for long-distance truck drivers may help reduce risky behavior that can lead to sexually transmitted infections (STIs), HIV and hepatitis C, say U.S. researchers. The researchers stationed mob...
Hepatitis B Vaccination Protects Against Liver Cancer
WEDNESDAY, Sept. 16 (HealthDay News) -- Vaccination at birth against hepatitis B virus greatly reduces the risk of liver cancer in young adulthood, new research suggests. In a 20-year study that followed infants who were vaccinated against the liv...
Genetic Discovery May Improve Hepatitis C Treatment
MONDAY, Aug. 17 (HealthDay News) -- The first biomarker that predicts a patient's response to hepatitis C treatments has been identified by U.S. researchers. The new marker is a single letter change -- a C instead of a T -- in a segment of DNA nea...
Top Hepatitis C Treatments Equally Effective
WEDNESDAY, July 22 (HealthDay News) -- A landmark hepatitis C virus study shows that the top two treatment options are equally effective and safe. The long-awaited study, thought to be the largest of its kind, is important for the 180 million peop...
New Treatment Combo Better Against Hepatitis C
WEDNESDAY, April 29 (HealthDay News) -- Adding the antiviral drug telaprevir to standard treatment for hepatitis C increases the cure rate, two new studies show. Current treatment for hepatitis C (HCV) genotype 1, the most common subtype, is a com...
Progress Reported Against Gene Involved in Hepatitis C
WEDNESDAY, March 18 (HealthDay News) -- Nearly 100 genes that support replication of the hepatitis C virus (HCV) in the human body have been identified by Massachusetts General Hospital researchers. They also found that blocking several of the gen...
Hispanics Respond Poorly to Standard Hepatitis C Therapy
WEDNESDAY, Jan. 14 (HealthDay News) -- The standard treatment for hepatitis C does not appear to help Hispanic whites with the liver disease as much as it helps non-Hispanic whites, a new study suggests. This is second major ethnic group -- the ot...
More Than 60,000 Patients Risked Hepatitis Infections
TUESDAY, Jan. 6 (HealthDay News) -- Failure to follow basic infection practices placed more than 60,000 U.S. patients at risk for hepatitis B and C, a new U.S. government review reported Tuesday. The review, published in the Jan. 6 issue of the jo...
Advertisement
